histori
paediatr
infecti
diseas
close
parallel
histori
paediatr
infect
remain
major
caus
childhood
morbid
mortal
viral
paediatr
infecti
diseas
characteris
great
heterogen
clinic
manifest
due
uniqu
characterist
neonat
period
childhood
almost
year
ago
paediatr
virolog
consid
isol
disciplin
includ
paediatr
infecti
diseas
section
scientif
field
paediatr
howev
past
two
decad
new
advanc
field
clinic
virolog
molecular
medicin
expand
level
knowledg
prevent
diagnosi
treatment
viral
infect
occur
infanc
childhood
reason
although
addit
subspecialist
sever
field
may
diminish
paediatr
virolog
bold
new
scientif
field
combin
paediatr
virolog
epidemiolog
molecular
medicin
evidencebas
medicin
clinic
govern
qualiti
improv
pharmacolog
immunolog
fig
date
paediatr
infecti
diseas
profession
achiev
distinct
role
within
scientif
field
paediatr
contribut
tertiari
paediatr
care
valu
current
clinic
research
aim
resolv
import
public
health
issu
develop
develop
countri
furthermor
new
emerg
diseas
sever
acut
respiratori
syndrom
sar
west
nile
viru
wnv
ebola
viru
ev
infect
requir
new
prevent
strategi
therapeut
protocol
addit
paediatr
infecti
diseas
profession
involv
specialis
paediatr
care
followup
children
histori
viral
infect
viral
mening
acquir
immunodefici
syndrom
aid
surviv
adolesc
year
beyond
requir
advanc
medic
care
technolog
servic
moreov
newfound
social
issu
arisen
includ
recent
antivaccin
wave
financi
crisi
unpreced
immigr
occur
global
mediterranean
countri
particular
develop
chang
definit
highlight
demand
continu
educ
paediatr
health
profession
inform
ongo
advanc
paediatr
care
manag
strategi
involv
disciplin
paediatr
virolog
world
congress
advanc
oncolog
intern
symposium
molecular
medicin
held
athen
greec
attend
particip
five
contin
annual
scientif
meet
attract
largest
number
deleg
date
period
three
day
uptod
basic
clinic
research
find
molecular
medicin
oncolog
present
discuss
first
time
year
third
day
meet
particip
chanc
particip
workshop
paediatr
virolog
theme
paediatr
virolog
lab
clinic
practic
fig
workshop
gather
world
expert
paediatr
neonatolog
virolog
vaccinolog
epidemiolog
microbiolog
public
health
cochair
professor
ann
greenough
professor
neonatolog
clinic
respiratori
physiolog
king
colleg
london
london
uk
vicepresid
royal
colleg
paediatr
child
health
rcpch
professor
anna
kramvi
research
professor
molecular
virolog
univers
witwatersrand
johannesburg
south
africa
professor
maria
theodorid
professor
paediatr
aghia
sophia
children
hospit
athen
greec
workshop
enthusiast
support
depart
clinic
virolog
school
medicin
univers
crete
heraklion
greec
first
depart
paediatr
school
medicin
univers
athen
athen
greec
initi
idea
birth
workshop
inspir
wirral
univers
teach
hospit
wirral
uk
cytomegaloviru
cmv
posit
twin
treat
local
neonat
intens
care
unit
nicu
requir
collabor
extend
scientif
network
merseysid
manchest
uk
manag
neonat
viral
infect
two
year
later
octob
oral
session
world
congress
advanc
oncolog
intern
meet
molecular
medicin
devot
human
papilloma
viru
hpv
infect
childhood
chair
professor
maria
theodorid
professor
paediatr
aghia
sophia
children
hospit
athen
greec
idea
reenforc
group
young
paediatr
traine
junior
research
lead
creation
paediatr
virolog
studi
group
pvsg
fundament
aim
pvsg
provid
array
scientif
educ
activ
bring
togeth
virolog
paediatr
within
singl
entiti
cover
basic
scienc
clinic
medicin
pvsg
open
scientist
interest
field
paediatr
virolog
either
basic
scientist
research
virologist
medic
student
paediatr
traine
gener
paediatrician
paediatr
infecti
diseas
physician
alli
health
profession
six
year
later
octob
pvsg
great
honour
coordin
workshop
paediatr
virolog
offici
session
world
congress
advanc
oncolog
intern
meet
molecular
medicin
workshop
dedic
promot
intern
scientif
exchang
cooper
clinician
research
paediatr
virolog
improv
biomed
research
paediatr
medic
practic
viral
infect
occur
childhood
review
present
updat
select
topic
present
workshop
respiratori
syncyti
viru
rsv
common
respiratori
pathogen
young
children
infect
children
requir
hospitalis
hospitalis
requir
mechan
ventil
numer
studi
demonstr
infant
born
term
previous
healthi
subsequ
rsv
lower
respiratori
tract
infect
lrti
develop
chronic
respiratori
morbid
mani
risk
factor
sever
acut
rsv
infect
includ
born
prematur
develop
bronchopulmonari
dysplasia
bpd
greenough
et
al
demonstr
school
age
prematur
born
children
develop
bpd
rsv
lrti
requir
hospitalis
infanc
increas
healthcar
utilis
wors
lung
function
particularli
affect
small
airway
children
bpd
hospitalis
due
rsv
healthcar
utilis
first
two
year
birth
also
shown
increas
even
moder
prematur
born
infant
week
gestat
hospitalis
due
rsv
two
prospect
follow
cohort
one
prematur
born
cohort
includ
preterm
infant
wide
rang
gestat
age
week
respiratori
morbid
greater
infanc
rsv
lrti
prematur
born
cohort
subsequ
respiratori
morbid
increas
rsv
lrti
regardless
whether
hospitalis
requir
infant
bpd
prematur
born
infant
requir
hospitalis
due
rsv
lrti
poorer
premorbid
lung
function
also
identifi
prematur
born
infant
may
genet
predisposit
develop
rsv
lrti
addit
singl
nucleotid
polymorph
snp
sever
gene
found
associ
chronic
respiratori
morbid
infanc
reduc
lung
function
one
year
follow
rsv
lrti
respiratori
viral
infect
also
advers
influenc
respiratori
outcom
infanc
born
prematur
includ
human
metapneumoviru
hmpv
human
rhinoviru
hrv
particularli
hrvc
poliomyel
acut
infecti
diseas
affect
human
occur
particularli
children
caus
small
ribonucl
acid
rna
virus
enteroviru
group
famili
picornavida
three
antigen
distinct
strain
strain
known
withtyp
account
case
clinic
manifest
diseas
vari
greatli
case
asymptomat
paralyt
ill
rare
affect
infect
individu
year
anniversari
sinc
jona
salk
launch
inactiv
polio
vaccin
ipv
enabl
children
protect
crippl
diseas
poliomyel
develop
oral
polio
vaccin
opv
albert
sabin
world
given
tool
stop
outbreak
strengthen
build
immun
ensur
children
grow
without
threat
polio
combin
opv
ipv
led
erad
polio
america
western
pacif
europ
today
world
popul
live
poliofre
region
nevertheless
pakistan
afghanistan
nigeria
countri
polio
still
categoris
endem
viral
infect
note
upsurg
polio
area
consid
poliofre
occur
confirm
circul
wildtyp
polioviru
wpv
israel
outbreak
acut
flaccid
paralysi
afp
syria
mean
high
risk
diseas
reintroduc
europ
europ
implement
prevent
polici
base
enhanc
vaccin
resid
refuge
popul
strengthen
surveil
prepar
rapidli
respond
identif
polio
greec
nation
action
plan
includ
programm
sustain
high
level
polio
immunis
coverag
afp
surveil
action
event
suspect
confirm
poliomyel
case
fight
polio
vaccin
one
success
public
health
programm
histori
reduc
number
polio
case
make
possibl
expect
toward
diseas
erad
even
though
success
vaccin
hbv
implement
countri
erad
hbv
still
horizon
accord
world
health
organ
million
chronic
carrier
viru
global
risk
develop
chronic
hepat
rang
newborn
hepat
b
e
antigen
hbeag
posit
mother
children
age
adult
hbeag
nonparticul
viral
protein
convent
consid
marker
hbv
replic
antigen
hbv
cross
placenta
lead
specif
unrespons
helper
cell
hepat
b
capsid
protein
hbcag
hbeag
newborn
hbeagposit
mother
hbeag
toler
utero
act
tolerogen
birth
thu
perinat
transmiss
frequent
mother
hbeagposit
wherea
occur
significantli
less
frequent
mother
hbeagneg
sequenc
heterogen
characterist
hbv
prototyp
member
famili
hepadnavirida
base
intergroup
diverg
across
complet
genom
hbv
classifi
phylogenet
least
genotyp
intergroup
nucleotid
diverg
across
complet
genom
good
bootstrap
support
genotyp
ad
f
h
classifi
subgenotyp
hbv
genotyp
case
subgenotyp
distinct
geograph
distribut
global
local
differ
genotypessubgenotyp
develop
differ
mutat
region
hbv
genom
code
hbeag
envelop
protein
differ
relat
role
hbv
genotyp
mode
transmiss
clinic
manifest
diseas
follow
hbv
infect
respons
antivir
therapi
thu
genotypessubgenotyp
hbv
may
respons
differ
mode
transmiss
natur
histori
infect
children
note
differ
region
world
distinct
genotypessubgenotyp
prevail
despit
invent
pap
smear
test
georg
n
papanicola
almost
year
ago
hpv
consid
frequent
carcinogen
human
caus
approxim
case
cervic
cancer
per
annum
major
case
occur
develop
countri
link
deoxyribonucl
acid
dna
viru
cervic
cancer
firstli
suspect
earli
professor
harald
zur
hausen
receiv
nobel
prize
physiolog
medicin
year
two
vaccin
hpv
bival
hpv
quadrival
hpv
implement
clinic
practic
sever
countri
worldwid
howev
despit
signific
calcul
expect
health
benefit
follow
implement
hpv
vaccin
programm
current
trend
indic
low
hpv
vaccin
uptak
among
femal
adolesc
sever
countri
europ
studi
also
focus
potenti
sociodemograph
factor
influenc
parent
decis
declin
hpv
vaccin
daughter
includ
age
ethnic
receipt
childhood
vaccin
knowledg
attitud
parent
commun
accept
note
greec
countri
financi
crisi
sinc
sever
health
qualiti
index
alreadi
deterior
financi
reason
also
elucid
behind
nonvaccin
hpv
sinc
data
hpv
vaccin
among
femal
adolesc
greec
remain
limit
first
pilot
crosssect
questionnairebas
studi
known
eleftheria
studi
expect
assess
hpv
vaccin
uptak
among
femal
adolesc
greec
period
investig
sociodemograph
reason
declin
hpv
vaccin
design
first
depart
paediatr
univers
athen
depart
clinic
virolog
univers
crete
name
inspir
eleftheria
name
first
adolesc
recruit
studi
preliminari
find
project
stress
need
provid
maintain
health
insur
coverag
children
countri
financi
crisi
reason
urgent
health
polici
respons
recent
financi
collaps
greec
requir
full
impact
auster
measur
unfold
come
year
ev
first
discov
caus
three
outbreak
two
simultan
one
exact
mode
transmiss
ev
remain
unknown
howev
seem
transmit
biolog
fluid
wild
anim
subsquent
humantohuman
contact
accord
west
african
outbreak
claim
case
fatal
rang
total
number
roughli
fatal
number
children
unknown
fact
make
potenti
lethal
tool
biowarfar
use
residenti
area
within
public
transport
system
biolog
agent
ev
easili
affect
welfar
life
children
emerg
depart
ed
readi
attack
especi
cater
need
paediatr
victim
carley
consensu
statement
formul
major
incid
plan
quit
help
local
tertiari
paediatr
hospit
peadiatr
unit
play
activ
role
coordin
care
children
plan
event
involv
children
carri
experienc
clinician
paediatr
approxim
equip
use
gener
hospit
suitabl
peadiatr
victim
age
staff
train
major
incid
regular
includ
care
children
triag
advis
use
modifi
adult
score
system
particular
triag
larg
number
children
eichelberg
modif
triag
revis
trauma
score
use
possibl
children
assess
treatment
well
transfer
need
provid
experienc
paediatr
team
allow
senior
clinician
parent
could
possibl
stay
site
near
children
hospitalis
follow
discharg
adequ
support
provid
famili
ed
readi
accommod
need
children
follow
ev
attack
offer
person
protect
equip
ppe
staff
appropri
decontamin
isol
facil
antidot
avail
well
gener
paediatr
equip
staff
alway
suspect
bioterror
sever
peopl
present
unusu
unexpect
symptom
symptom
conform
certain
medic
diagnosi
identifi
isol
inform
current
standard
approach
ev
suspicion
hope
none
actual
need
near
futur
viral
bronchiol
mainli
caus
rsv
infect
remain
lead
caus
infant
admiss
picu
recent
laboratori
tool
also
confirm
mani
virus
account
bronchiol
either
coinfect
rsv
aetiolog
pathogen
virus
hrv
hmpv
adenoviru
well
influenza
parainfluenza
virus
even
follow
antirsv
postprophylaxi
era
rsv
seem
common
caus
bronchiol
infanc
respons
sever
clinic
manifest
longer
hospitalis
picu
admiss
sever
bronchiol
indic
persist
increas
respiratori
effort
tachypnoea
nasal
flare
intercost
subcost
suprastern
retract
accessori
muscl
use
grunt
hypoxaemia
apnoea
acut
respiratori
failur
risk
factor
sever
diseas
andor
complic
bronchiol
even
death
consid
prematur
gestat
age
week
age
week
chronic
pulmonari
diseas
particularli
bpd
also
known
chronic
lung
diseas
congenit
anatom
defect
airway
congenit
heart
diseas
immunodefici
neurolog
diseas
though
common
old
clinic
entiti
wide
varieti
clinic
practic
need
clarifi
therapeut
mean
done
larg
welldesign
clinic
studi
come
treatment
critic
ill
children
pauciti
evidencebas
guidelin
fluid
replac
oxygen
supplement
close
monitor
first
step
manag
diseas
role
epinephrin
nebulis
bronchodil
combin
system
corticosteroid
question
given
individualis
basi
nebulis
hyperton
salin
new
therapeut
agent
investig
possibl
use
picu
although
recommend
use
remain
establish
therapi
heliox
surfact
ribavirin
also
examin
controversi
result
thu
far
littl
seem
achiev
come
treatment
lot
emphasi
given
prevent
ill
hygien
measur
educ
caregiv
hospit
personnel
nurs
doctor
limit
transmiss
elimin
environment
risk
factor
strongli
recommend
publish
guidelin
palivizumab
prophylaxi
recommend
infant
risk
factor
chronic
ill
prematur
immunodefici
well
condit
clarifi
revis
publish
guidelin
sinc
burden
rsv
bronchiol
high
research
must
aim
develop
antirsv
vaccin
well
new
antivir
agent
autism
sever
neurodevelopment
disord
affect
paediatr
popul
autism
spectrum
disord
asd
includ
disord
psychomotor
regress
languag
impair
behaviour
social
withdraw
place
patient
asd
perman
need
healthcar
social
support
earlier
report
associ
vaccin
mmr
occurr
asd
children
thu
lead
particularli
low
vaccin
coverag
result
outbreak
regard
vaccin
prevent
strain
reappear
throughout
europ
asia
unit
state
extens
research
around
issu
emerg
soundli
dissoci
mmr
vaccin
asd
occurr
even
highrisk
popul
howev
loss
credibl
mmr
vaccin
remain
concern
partial
explain
failur
behalf
scientif
commun
effect
commun
limit
bia
origin
studi
wakefield
et
al
ii
mount
evid
support
lack
causal
relationship
mmr
vaccin
receipt
autism
onset
proven
larg
epidemiolog
studi
iii
advers
effect
vaccin
gener
set
coincident
rather
causal
associ
anoth
contribut
factor
must
attribut
power
influenc
public
media
televis
newspap
internet
regard
mmr
vaccin
ultim
lead
subsequ
neg
public
health
respons
futur
effect
commun
strategi
requir
reassur
parent
vaccin
safeti
import
ocular
manifest
viral
infect
neonat
children
vari
greatli
rang
innocu
vision
threaten
major
viral
conjunct
children
caus
adenoviru
dna
viru
caus
rang
human
diseas
includ
upper
respiratori
tract
infect
viral
conjunct
associ
epidem
keratoconjunct
pharyngoconjunctiv
fever
acut
haemorrhag
conjunct
sign
includ
eyelid
oedema
tender
preauricular
lymphadenopathi
promin
conjunctiv
hyperaemia
follicl
punctat
epitheli
kerat
viral
infect
children
involv
anterior
segment
mild
selflimit
spontan
resolut
usual
occur
within
week
except
case
congenit
infect
often
associ
signific
alter
ocular
structur
neonat
conjunct
also
known
ophthalmia
neonatorum
defin
conjunctiv
inflamm
develop
within
first
month
life
common
type
infect
neonat
occur
neonat
often
identifi
specif
entiti
distinct
conjunct
older
infant
often
result
infect
transmit
mother
infant
deliveri
molluscum
contagiosum
ocular
infect
children
caus
specif
doublestrand
dna
poxviru
typic
affect
otherwis
healthi
children
peak
incid
age
two
four
transmiss
occur
contact
subsequ
autoinocul
present
chronic
unilater
ocular
irrit
mild
discharg
lesion
usual
selflimit
primari
infect
herp
simplex
viru
hsv
usual
associ
eyelid
periorbit
vesicl
papillari
conjunct
discharg
lid
swell
dendrit
corneal
ulcer
also
present
particularli
patient
atop
infect
lead
eczema
herpeticum
sever
varicellazost
viru
vzv
seriou
rare
viral
infect
children
prolong
inflamm
may
lead
corneal
thin
perfor
glaucoma
cataract
format
involv
posterior
structur
mostli
relat
hsv
vzv
potenti
sightthreaten
retin
optic
nerv
involv
suspect
child
complain
acut
onset
blur
vision
absenc
anterior
segment
inflamm
opac
ocular
media
optic
neuropathi
may
occur
isol
sign
although
often
associ
generalis
involv
central
nervou
system
specif
therapi
alway
avail
earli
diagnosi
ocular
viral
diseas
children
aid
amelior
acut
symptom
prevent
longterm
complic
hpv
respons
mani
benign
lesion
airway
tract
genit
area
adult
popul
well
cancer
larynx
oral
caviti
particularli
subtyp
recent
studi
also
reveal
increas
frequenc
hpv
infect
neonat
children
otorhinolaryngologist
specialist
treat
children
hpvrelat
lesion
localis
oral
caviti
oropharynx
larynx
lesion
mostli
benign
four
type
hpvrelat
lesion
concern
upper
airway
track
squamou
papilloma
ii
verruca
vulgari
iii
focal
epitheli
hyperplasia
iv
condyloma
acuminatum
children
common
clinic
express
hpv
recurr
respiratori
papillomatosi
rrp
caus
hoars
voic
sometim
lesion
caus
obstruct
upper
airway
track
adult
clinic
behaviour
differ
diseas
requir
fewer
surgic
excis
children
children
lesion
caus
hpv
often
need
mani
surgic
procedur
becom
extinct
quiescent
invert
papilloma
type
squamou
papilloma
strongli
associ
hpv
subtyp
incid
children
twice
high
compar
adult
fortun
major
lesion
surgic
remov
provid
young
patient
good
prognosi
microsurgeri
transor
laser
microsurgeri
tlm
endoscop
endonas
approach
eea
frequent
surgic
method
excis
review
recent
studi
deal
hpv
lesion
children
reveal
case
treat
surgic
common
approach
surgic
treatment
use
tlm
howev
laser
treatment
caus
sever
complic
stenosi
burn
airway
tract
scar
altern
tlm
microdebrid
microdebrid
provid
accur
excis
remov
affect
tissu
preserv
healthi
tissu
preserv
healthi
epithelium
use
repeat
intervent
need
particularli
children
lesion
caus
obstruct
airway
tract
tracheotomi
necessari
keep
airway
open
howev
avoid
perform
emerg
danger
spread
diseas
respiratori
tract
futur
associ
hpvrelat
lesion
children
cancer
lesion
adult
need
consid
care
reveal
import
vaccin
children
hpv
im
main
clinic
manifest
epstein
barr
viru
ebv
infect
agent
cmv
toxoplasma
adenoviru
produc
similar
ill
incub
period
rang
day
clinic
present
usual
prolong
averag
day
rang
nonspecif
flulik
ill
distinct
triad
fever
pharyng
lymphadenopathysplenomegali
clinic
manifest
includ
fatigu
hepat
eyelid
oedema
possibl
complic
meningoenceph
haemolyt
anaemia
thrombocytopenia
rash
conjunct
haemophagocyt
syndrom
myocard
neurolog
diseas
pancreat
parot
pericard
pneumon
psycholog
disord
splenic
ruptur
laboratori
find
includ
elev
liver
enzym
lymphocytosi
mark
increas
number
atyp
lymphocyt
peripher
blood
addit
immunophenotyp
alter
lymphocyt
describ
variou
phase
ebv
infect
specif
reduct
blymphocyt
increas
number
tlymphocyt
subsequ
decreas
ratio
note
studi
panagopoul
et
al
present
workshop
research
aim
examin
whether
associ
immunophenotyp
alter
variabl
clinic
present
im
although
sever
studi
examin
immunophenotyp
lymphocyt
ebv
infect
correl
clinic
cours
present
studi
show
immunophenotyp
analysi
cytotox
cell
provid
import
inform
physiolog
immun
respons
ebv
infect
addit
may
potenti
play
predict
role
provid
inform
expect
clinic
cours
potenti
complic
time
recoveri
ebv
infect
mcpyv
newlydiscov
small
human
dna
viru
caus
widespread
previous
unrecognis
human
infect
adulthood
childhood
classifi
famili
polyomavirida
group
nonenvelop
doublestrand
dna
virus
icosahedr
symmetri
infect
varieti
vertebr
includ
human
caus
malign
tumour
upon
inocul
heterolog
host
first
describ
januari
prototyp
sequenc
mcpyv
base
pair
genom
contain
earli
region
encod
larg
tumor
lt
antigen
small
tumour
st
antigen
altern
tumor
antigen
open
read
frame
alto
late
region
encod
vp
vp
vp
noncod
regulatori
region
note
genom
mcpyv
detect
approxim
merkel
cell
carcinoma
mcc
case
although
mcc
rel
rare
highli
aggress
human
skin
cancer
neuroendocrin
origin
worldwid
incid
increas
past
twenti
year
case
per
year
major
mcc
case
mcpyv
integr
host
genom
monoclon
manner
viral
antigen
truncat
mutat
render
antigen
unabl
initi
dna
replic
requir
propag
viru
recent
serolog
data
use
enzymelink
immunosorb
assay
elisa
techniqu
suggest
mcpyv
infect
common
childhood
occur
earli
childhood
disappear
specif
matern
antibodi
mcpyv
mcpyv
dna
detect
nasopharyng
aspir
sampl
collect
children
indic
presenc
mcpyv
upper
respiratori
tract
children
mcpyv
acquir
childhood
close
contact
involv
saliva
skin
date
mode
mcpyv
transmiss
fulli
elucid
precis
role
respiratori
secret
mcpyv
transmiss
childhood
requir
investig
respiratori
tract
system
involv
uniqu
reservoir
mcpyv
children
respiratori
secret
seem
play
signific
role
mcpyv
transmiss
childhood
moreov
futur
studi
requir
order
fulli
elucid
potenti
implic
mcpyv
infect
neoplasm
children
